Skip to main content

Advertisement

Log in

Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

  • Original Research
  • Published:
Brain Imaging and Behavior Aims and scope Submit manuscript

Abstract

Dementia with Lewy bodies (DLB) is often associated with occipital hypometabolism or hypoperfusion, as well as deficits in cholinergic neurotransmission. In this study, 11 mild DLB, 16 mild AD and 16 age-matched controls underwent arterial spin-labeled perfusion MRI (ASL-pMRI) and neuropsychological testing. Patterns of cerebral blood flow (CBF) and cognitive performance were compared. In addition, combined ASL-pMRI and ChEI drug challenge (pharmacologic MRI) was tested as a probe of cholinergic function in 4 of the DLB participants. Frontal and parieto-occipital hypoperfusion was observed in both DLB and AD but was more pronounced in DLB. Following ChEI treatment, perfusion increased in temporal and parieto-occipital cortex, and cognitive performance improved on a verbal fluency task. If confirmed in a larger study, these results provide further evidence for brain cholinergic dysfunction in DLB pathophysiology, and use of pharmacologic MRI as an in vivo measure of cholinergic function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aarsland, D., Litvan, I., Salmon, D. P., Galasko, D., Wentzel-Larsen, T., & Larsen, J. (2003). Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, 1215–1220.

    Article  CAS  Google Scholar 

  • Ala, T. A., Hughes, L. F., Kyrouac, G. A., Ghobrial, M. W., & Elble, R. J. (2002). The mini-mental state exam may help in the differentiation of dementia with Lewy bodies and Alzheimer’s disease. International Journal of Geriatric Psychiatry, 17(6), 503–509.

    Article  PubMed  Google Scholar 

  • Albin, R. L., Minoshima, S., D’Amato, C. J., Frey, K. A., Kuhl, D. A., & Sima, A. A. (1996). Fluro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology, 47, 462–466.

    CAS  PubMed  Google Scholar 

  • Alsop, D. C., & Detre, J. A. (1998). Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology, 208, 410–416.

    CAS  PubMed  Google Scholar 

  • Alsop, D. C., Casement, M., de Bazelaire, C., Fong, T., & Press, D. Z. (2008). Hippocampal hyperperfusion in Alzheimer’s disease. Neuroimage, 42(4), 1267–1274.

    Article  PubMed  Google Scholar 

  • Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., et al. (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and Hippocampal sclerosis in the state of Florida brain bank. Alzheimer Disease and Associated Disorders, 16(4), 203–212.

    Article  PubMed  Google Scholar 

  • Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Koeppe, R. A., et al. (2005). Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by Donepezil treatment in Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 76(3), 315–319.

    Article  CAS  Google Scholar 

  • Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24(2), 197–211.

    Article  PubMed  Google Scholar 

  • Cavanna, A. E., & Trimble, M. R. (2006). The precuneus: a review of its functional anatomy and behavioural correlates. Brain, 129(Pt 3), 564-583.

    Google Scholar 

  • Colloby, S. J., Fenwick, J. D., Williams, E. D., Paling, S. M., Lobotesis, K., Ballard, C., et al. (2002). A comparison of (99M)TC-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging, 29(5), 615–622.

    Article  PubMed  Google Scholar 

  • Dai, W., Garcia, D., de Bazelaire, C., & Alsop, D. C. (2008). Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magnetic Resonance in Medicine, 60(6), 1488–1497.

    Article  PubMed  Google Scholar 

  • Defebvre, L. J., Leduc, V., Duhamel, A., Lecouffe, P., Pasquier, F., Lamy-Lhullier, C., et al. (1999). Technetium HMPAO spect study in dementia with Lewy bodies, Alzheimer’s disease and idiopathic Parkinson’s disease. Journal of Nuclear Medicine, 40(6), 956–962.

    CAS  PubMed  Google Scholar 

  • DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., et al. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology, 51, 145–155.

    Article  CAS  PubMed  Google Scholar 

  • Detre, J. A., & Alsop, D. C. (1999). Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. European Journal of Radiology, 30(2), 115–124.

    Article  CAS  PubMed  Google Scholar 

  • Detre, J. A., Wang, J., Wang, Z., & Rao, H. (2009). Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Current Opinion in Neurology, 22(4), 348–355.

    Article  PubMed  Google Scholar 

  • Ebmeier, K. P., Hunter, R., Curran, S. M., Dougal, N. J., Murray, C. L., Wyper, D. J., et al. (1992). Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer’s disease. Psychopharmacology (Berl), 108(1–2), 103–109.

    Article  CAS  Google Scholar 

  • Firbank, M. J., Burn, D. J., McKeith, I. G., & O’Brien, J. T. (2005). Longitudinal study of cerebral blood flow spect in Parkinson’s disease with dementia, and dementia with Lewy bodies. International Journal of Geriatric Psychiatry, 20(8), 776–782.

    Article  PubMed  Google Scholar 

  • Floyd, T., Ratcliffe, S., Wang, J., Resch, B., & Detre, J. (2003). Precision of the casl-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. Journal of Magnetic Resonance Imaging, 18, 649–655.

    Article  PubMed  Google Scholar 

  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental-state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.

    Article  CAS  PubMed  Google Scholar 

  • Francis, P. T., & Perry, E. K. (2007). Cholinergic and other neurotransmitter mechanisms in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. Movement Disorders, 22(Suppl 17), S351–S357.

    Article  PubMed  Google Scholar 

  • Geaney, D. P., Soper, N., Shepstone, B. J., & Cowen, P. J. (1990). Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet, 335(8704), 1484–1487.

    Article  CAS  PubMed  Google Scholar 

  • Imamura, T., Ishii, K., Hirono, N., & Al, E. (1999). Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). NeuroReport, 10, 1903–1907.

    Article  CAS  PubMed  Google Scholar 

  • Ishii, K., Imamura, T., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., et al. (1998). Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease. Neurology, 51(1), 125–130.

    CAS  PubMed  Google Scholar 

  • Ishii, K., Soma, T., Kono, A. K., Sofue, K., Miyamoto, N., Yoshikawa, T., et al. (2007). Comparison of regional brain volume and glucose metabolism between patients with mild dementia with Lewy bodies and those with mild Alzheimer’s disease. Journal of Nuclear Medicine, 48(5), 704–711.

    Article  PubMed  Google Scholar 

  • Kemp, P. M., Hoffmann, S. A., Tossici-Bolt, L., Fleming, J. S., & Holmes, C. (2007). Limitations of the HMPAO spect appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nuclear Medicine Communications, 28(6), 451–456.

    Article  PubMed  Google Scholar 

  • Klein, J. C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., et al. (2010). Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology, 74(11), 885–892.

    Article  CAS  PubMed  Google Scholar 

  • Lobotesis, K., Fenwick, J. D., Phipps, A., Ryman, A., Swann, A., Ballard, C., et al. (2001). Occipital hypoperfusion on spect in dementia with Lewy bodies but not ad. Neurology, 56(5), 643–649.

    CAS  PubMed  Google Scholar 

  • McKeith, I. G. (2002). Dementia with Lewy bodies. The British Journal of Psychiatry, 180, 144–147.

    Article  PubMed  Google Scholar 

  • McKeith, I. G. (2006). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Journal of Alzheimer's Disease, 9(3 Suppl), 417–423.

    PubMed  Google Scholar 

  • McKeith, I. G., Grace, J. B., Walker, Z., Byrne, E. J., Wilkinson, D., Stevens, T., et al. (2000). Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. International Journal of Geriatric Psychiatry, 15(5), 387–392.

    Article  CAS  PubMed  Google Scholar 

  • Mori, T., Ikeda, M., Fukuhara, R., Nestor, P. J., & Tanabe, H. (2006). Correlation of visual hallucinations with occipital RCBF changes by Donepezil in DLB. Neurology, 66(6), 935–937.

    Article  CAS  PubMed  Google Scholar 

  • Palmqvist, S., Hansson, O., Minthon, L., & Londos, E. (2009). Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer’s disease with common cognitive tests. International Journal Geriatric Psychiatry.

  • Parkes, L. M., Rashid, W., Chard, D. T., & Tofts, P. S. (2004). Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magnetic Resonance in Medicine, 51(4), 736–743.

    Article  PubMed  Google Scholar 

  • Pasquier, J., Michel, B. F., Brenot-Rossi, I., Hassan-Sebbag, N., Sauvan, R., & Gastaut, J. L. (2002). Value of (99M)TC-ECD Spet for the diagnosis of dementia with Lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging, 29(10), 1342–1348.

    Article  CAS  PubMed  Google Scholar 

  • Salmon, D. P., Galasko, D., & Hansen, L. A. (1996). Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition, 31, 148–165.

    Article  CAS  PubMed  Google Scholar 

  • Sato, A., & Sato, Y. (1992). Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Neuroscience Research, 14(4), 242–274.

    Article  CAS  PubMed  Google Scholar 

  • Sato, A., Sato, Y., & Uchida, S. (2002). Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging. Autonomic Neuroscience, 96(1), 13–19.

    Article  CAS  PubMed  Google Scholar 

  • Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., et al. (2009). Mapping of brain acetylcholinesterase alterations in Lewy body disease by pet. Neurology, 73(4), 273–278.

    Article  CAS  PubMed  Google Scholar 

  • Tierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., et al. (1988). The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology, 38(3), 359–364.

    CAS  PubMed  Google Scholar 

  • Tiraboschi, P., Hansen, L. A., Alford, M., Merdes, A., Masliah, E., Thal, L. J., et al. (2002). Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry, 59(10), 946–951.

    Article  PubMed  Google Scholar 

  • Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage, 15(1), 273–289.

    Article  CAS  PubMed  Google Scholar 

  • Varma, A. R., Talbot, P. R., Snowden, J. S., Lloyd, J. J., Testa, H. J., & Neary, D. (1997). A 99MTC-HMPAO single-photon emission computed tomography study of Lewy body disease. Journal of Neurology, 244(6), 349–359.

    Article  CAS  PubMed  Google Scholar 

  • Venneri, A., Shanks, M. F., Staff, R. T., Pestell, S. J., Forbes, K. E., Gemmell, H. G., et al. (2002). Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer’s disease. NeuroReport, 13(1), 83–87.

    Article  CAS  PubMed  Google Scholar 

  • Whitwell, J. L., Weigand, S. D., Shiung, M. M., Boeve, B. F., Ferman, T. J., Smith, G. E., et al. (2007). Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer’s disease. Brain, 130(Pt 3), 708–719.

    Article  PubMed  Google Scholar 

  • Williams, D. S., Detre, J. A., Leigh, J. S., & Koretsky, A. P. (1992). Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proceedings of the National Academy of Sciences of the United States of America, 89(1), 212–216.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The authors report no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tamara G. Fong.

Additional information

Supported in part by F32NS047431(Fong) from the National Institute of Neurological Disorders and Stroke, K23AG031320 (Fong), K24AG000949 (Inouye) and RO1AG19599 (Alsop) from the National Institute on Aging, IIRG-08-88737 (Inouye) from the Alzheimer’s Association, and the Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife. Support provided to Dr. Fong, Department of Neurology, Beth Israel Deaconess Medical Center and the Clinical Investigator Training Program: Beth Israel Deaconess Medical Center - Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer Inc. and Merck & Co., and in part by the John A. Hartford Harvard Center of Excellence. Dr. Inouye holds the Milton and Shirley F. Levy Family Chair. Study medications (donepezil and placebo) were provided by a grant from Pfizer/Eisai, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fong, T.G., Inouye, S.K., Dai, W. et al. Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?. Brain Imaging and Behavior 5, 25–35 (2011). https://doi.org/10.1007/s11682-010-9108-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11682-010-9108-x

Keywords

Navigation